Most importantly, the same results were obtained when necrotic supernatants were added to live DU145 tumor cells undergoing DTX treatment (Fig. 4B), supporting our notion that dying cells release HMGB1 in the supernatant that can bind tumor cells to confer drug resistance through sCLU induction. Here, HMGB1 is linked to neoplasm.